Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 311

1.

Development and Validation of an Electronic Medical Record Algorithm to Identify Phenotypes of Rotator Cuff Tear.

Gao C, Fan R, Ayers GD, Giri A, Harris K, Atreya R, Teixeira PL, Jain NB.

PM R. 2020 Mar 20. doi: 10.1002/pmrj.12367. [Epub ahead of print]

PMID:
32198840
2.

Phase 2 Study of Hyper-CMAD with Liposomal Vincristine for Patients with Newly Diagnosed Acute Lymphoblastic Leukemia.

Sasaki K, Kantarjian H, Wierda W, Ravandi F, Daver N, Burger J, DiNardo CD, Jain N, Short NJ, Estrov Z, Konopleva M, Ohanian M, Garcia-Manero G, Kadia T, Alvarado Y, Yilmaz M, Pierce S, Garris R, Cortes J, O'Brien S, Ingram A, Jabbour E.

Am J Hematol. 2020 Mar 14. doi: 10.1002/ajh.25784. [Epub ahead of print]

PMID:
32170867
3.

The protocol for a multisite, double blind, randomized, placebo-controlled trial of axillary nerve stimulation for chronic shoulder pain.

Cleland T, Jain NB, Chae J, Hansen KM, Hisel TZ, Gunzler DD, Whitehair VC, Kim CH, Wilson RD.

Trials. 2020 Mar 6;21(1):248. doi: 10.1186/s13063-020-4174-x.

4.

Risk factors for surgery due to rotator cuff disease in a population-based cohort.

Yanik EL, Colditz GA, Wright RW, Saccone NL, Evanoff BA, Jain NB, Dale AM, Keener JD.

Bone Joint J. 2020 Mar;102-B(3):352-359. doi: 10.1302/0301-620X.102B3.BJJ-2019-0875.R1.

PMID:
32114822
5.

A phase 1/2 study of ruxolitinib and decitabine in patients with post-myeloproliferative neoplasm acute myeloid leukemia.

Bose P, Verstovsek S, Cortes JE, Tse S, Gasior Y, Jain N, Jabbour EJ, Estrov Z, Alvarado Y, DiNardo CD, Pemmaraju N, Kornblau SM, Kadia TM, Daver NG, Naqvi K, Short NJ, Masarova L, Villareal J, Pierce SA, Nogueras-Gonzalez G, Huang X, Garcia-Manero G, Kantarjian HM, Ravandi F.

Leukemia. 2020 Feb 25. doi: 10.1038/s41375-020-0778-0. [Epub ahead of print] No abstract available.

PMID:
32099037
6.

A phase 1 study of azacitidine with high-dose cytarabine and mitoxantrone in high-risk acute myeloid leukemia.

Cahill KE, Karimi YH, Karrison TG, Jain N, Green M, Weiner H, Fulton N, Kadri S, Godley LA, Artz AS, Liu H, Thirman MJ, Le Beau MM, McNerney ME, Segal J, Larson RA, Stock W, Odenike O.

Blood Adv. 2020 Feb 25;4(4):599-606. doi: 10.1182/bloodadvances.2019000795.

7.

Clinical Experience With Venetoclax Combined With Chemotherapy for Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia.

Richard-Carpentier G, Jabbour E, Short NJ, Rausch CR, Savoy JM, Bose P, Yilmaz M, Jain N, Borthakur G, Ohanian M, Alvarado Y, Rytting M, Kebriaei P, Konopleva M, Kantarjian H, Ravandi F.

Clin Lymphoma Myeloma Leuk. 2019 Sep 30. pii: S2152-2650(19)31995-0. doi: 10.1016/j.clml.2019.09.608. [Epub ahead of print]

PMID:
32035785
8.

Loncastuximab tesirine, an anti-CD19 antibody-drug conjugate, in relapsed/refractory B-cell acute lymphoblastic leukemia.

Jain N, Stock W, Zeidan A, Atallah E, McCloskey J, Heffner L, Tomlinson B, Bhatnagar B, Feingold J, Ungar D, Chao G, Zhang X, Qin Y, Havenith K, Kantarjian H, Wieduwilt MJ.

Blood Adv. 2020 Feb 11;4(3):449-457. doi: 10.1182/bloodadvances.2019000767.

9.

Pinch-off syndrome: a rare and serious complication of central venous catheters.

Hadid T, Hernandez M, Zeni A, Jain N.

BMJ Case Rep. 2020 Jan 13;13(1). pii: e233779. doi: 10.1136/bcr-2019-233779. No abstract available.

PMID:
31937632
10.

Recommendations by a UK expert panel on an aflibercept treat-and-extend pathway for the treatment of neovascular age-related macular degeneration.

Ross AH, Downey L, Devonport H, Gale RP, Kotagiri A, Mahmood S, Mehta H, Narendran N, Patel PJ, Parmar N, Jain N.

Eye (Lond). 2020 Jan 3. doi: 10.1038/s41433-019-0747-x. [Epub ahead of print]

PMID:
31900438
11.

Achieving complete remission in CLL patients treated with ibrutinib: clinical significance and predictive factors.

Strati P, Schlette EJ, Solis Soto LM, Duenas DE, Sivina M, Kim E, Keating MJ, Wierda WG, Ferrajoli A, Kantarjian H, Estrov Z, Jain N, Thompson PA, Wistuba II, Burger JA.

Blood. 2020 Feb 13;135(7):510-513. doi: 10.1182/blood.2019003570. No abstract available.

PMID:
31895947
12.

The BET inhibitor GS-5829 targets chronic lymphocytic leukemia cells and their supportive microenvironment.

Kim E, Ten Hacken E, Sivina M, Clarke A, Thompson PA, Jain N, Ferrajoli A, Estrov Z, Keating MJ, Wierda WG, Bhalla KN, Burger JA.

Leukemia. 2019 Dec 20. doi: 10.1038/s41375-019-0682-7. [Epub ahead of print]

PMID:
31862959
13.

US Geographical Variation in Rates of Shoulder and Knee Arthroscopy and Association With Orthopedist Density.

Jain NB, Peterson E, Ayers GD, Song A, Kuhn JE.

JAMA Netw Open. 2019 Dec 2;2(12):e1917315. doi: 10.1001/jamanetworkopen.2019.17315.

14.

Surgery for rotator cuff tears.

Karjalainen TV, Jain NB, Heikkinen J, Johnston RV, Page CM, Buchbinder R.

Cochrane Database Syst Rev. 2019 Dec 9;12:CD013502. doi: 10.1002/14651858.CD013502. Review.

PMID:
31813166
15.

What's New in Orthopaedic Rehabilitation.

Cleland TL, Wilson R, Kim C, Jain NB.

J Bone Joint Surg Am. 2019 Nov 20;101(22):1983-1989. doi: 10.2106/JBJS.19.00811. No abstract available.

PMID:
31764360
16.

The Shifting Paradigm in Chronic Lymphocytic Leukemia: Is Chemotherapy Still Relevant?

Jain N, O╩╝Brien S.

Cancer J. 2019 Nov/Dec;25(6):374-377. doi: 10.1097/PPO.0000000000000417.

PMID:
31764117
17.

Recommendations for Enhancing Sports Medicine Fellowship Training.

Jain NB, Borg-Stein J, Miranda-Comas G, Micheo W, Visco C, Fredericson M.

Am J Phys Med Rehabil. 2020 Apr;99(4):348-352. doi: 10.1097/PHM.0000000000001332.

PMID:
31738281
18.

The early achievement of measurable residual disease negativity in the treatment of adults with Philadelphia-negative B-cell acute lymphoblastic leukemia is a strong predictor for survival.

Yilmaz M, Kantarjian H, Wang X, Khoury JD, Ravandi F, Jorgensen J, Short NJ, Loghavi S, Cortes J, Garcia-Manero G, Kadia T, Sasaki K, Konopleva M, Takahashi K, Wierda W, Jain N, Verstovsek S, Estrov Z, Bose P, Pierce S, Garris R, O'Brien S, Jabbour E.

Am J Hematol. 2020 Feb;95(2):144-150. doi: 10.1002/ajh.25671. Epub 2019 Nov 19.

PMID:
31682008
19.

STAT3-Induced Wnt5a Provides Chronic Lymphocytic Leukemia Cells with Survival Advantage.

Rozovski U, Harris DM, Li P, Liu Z, Jain P, Ferrajoli A, Burger JA, Bose P, Thompson PA, Jain N, Wierda WG, Uziel O, Keating MJ, Estrov Z.

J Immunol. 2019 Dec 1;203(11):3078-3085. doi: 10.4049/jimmunol.1900389. Epub 2019 Oct 23.

PMID:
31645416
20.

What's New in Orthopaedic Rehabilitation.

Cleland TL, Wilson R, Kim C, Jain NB.

J Bone Joint Surg Am. 2019 Oct 9. doi: 10.2106/JBJS.19.00811. [Epub ahead of print] No abstract available.

PMID:
31596813

Supplemental Content

Loading ...
Support Center